We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Couvet

News List

BMS Completes Sale of Couvet Site to WuXi STA contractpharma
August 05, 2021
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to WuXi STA, a subsidiary of WuXi AppTec.
WuXi STA completes acquisition of its first European facility cphi-online
August 05, 2021
The purchase of BMS's Couvet, Switzerland facility adds commercial-scale production capacity for capsule and tablet dosage forms
WuXi STA Completes Acquisition of BMS Manufacturing Facility contractpharma
August 04, 2021
State-of-the-art facility in Couvet, Switzerland enhances WuXi STA's drug product capacity in Europe.
WuXi STA to buy Swiss pharma manufacturing facility from Bristol Myers Squibb pharmaceutical-business-review
February 07, 2021
WuXi STA, a subsidiary of Chinese pharmaceutical company WuXi AppTec, has agreed to buy the Couvet, Switzerland-based manufacturing facility from Bristol Myers Squibb.